-
Cotation en bourse
-
Trading
Where European Government Bonds meet the futureFixed Income derivativesLire la suiteTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLire la suiteEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLire la suiteEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lire la suiteThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLire la suiteThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lire la suiteShaping capital markets for future generations
Congrès annuel Life Sciences
21/05/2015
Ouverture de "Knowledge for Growth" – le congrès annuel Life Sciences
Le 21 mai 2015, Hilde Windels, CFO de Biocartis; Tim Van Hauwermeiren, CEO d’arGEN-X et Michel Helbig de Balzac, Chairman de Bone Therapeutics ont sonné la cloche pour ouvrir les marchés d’Euronext lors du congrès annuel de FlandersBio à Gand. FlandersBio est la plus grande conférence biotech régionale de l'Europe. Les membres du Conseil d’Administration de FlandersBio et son directeur général, Henk Joos, étaient également présents.
Pour en savoir plus : www.Knowledgeforgrowth.be